UnitedHealth Historical Financial Ratios
| UNH Stock | USD 493.18 14.19 2.96% |
UnitedHealth Group is promptly reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 1.17, Dividend Yield of 0.0145, PTB Ratio of 3.18 or Days Sales Outstanding of 40.19 will help investors to properly organize and evaluate UnitedHealth Group financial condition quickly.
UnitedHealth |
About UnitedHealth Financial Ratios Analysis
UnitedHealth GroupFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate UnitedHealth Group investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on UnitedHealth financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across UnitedHealth Group history.
UnitedHealth Group Financial Ratios Chart
UnitedHealth Group Incorporated financial ratios usually calculated using numerical values taken directly from UnitedHealth Group financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about UnitedHealth Group. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
As of now, UnitedHealth Group's Free Cash Flow Yield is decreasing as compared to previous years. The UnitedHealth Group's current Operating Cash Flow Per Share is estimated to increase to 32.89, while Price To Sales Ratio is projected to decrease to 1.17. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing UnitedHealth Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on UnitedHealth Group sales, a figure that is much harder to manipulate than other UnitedHealth Group Incorporated multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is UnitedHealth Group Incorporated dividend as a percentage of UnitedHealth Group stock price. UnitedHealth Group dividend yield is a measure of UnitedHealth Group stock productivity, which can be interpreted as interest rate earned on an UnitedHealth Group investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from UnitedHealth Group's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into UnitedHealth Group current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. As of now, UnitedHealth Group's Free Cash Flow Yield is decreasing as compared to previous years. The UnitedHealth Group's current Operating Cash Flow Per Share is estimated to increase to 32.89, while Price To Sales Ratio is projected to decrease to 1.17.
| 2021 | 2022 | 2024 (projected) | Dividend Yield | 0.0112 | 0.0121 | 0.0145 | Price To Sales Ratio | 1.66 | 1.54 | 1.17 |
UnitedHealth Group fundamentals Correlations
Click cells to compare fundamentals
UnitedHealth Group Account Relationship Matchups
High Positive Relationship
High Negative Relationship
UnitedHealth Group fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.16 | 1.3 | 1.66 | 1.54 | 1.31 | 1.17 | |
| Dividend Yield | 0.013 | 0.0138 | 0.0141 | 0.0112 | 0.0121 | 0.0145 | |
| Ptb Ratio | 4.63 | 4.87 | 6.31 | 6.1 | 5.5 | 3.18 | |
| Days Sales Outstanding | 17.96 | 18.38 | 18.19 | 20.03 | 38.28 | 40.19 | |
| Book Value Per Share | 56.41 | 63.55 | 79.58 | 86.93 | 95.64 | 100.42 | |
| Free Cash Flow Yield | 0.0586 | 0.0605 | 0.042 | 0.0471 | 0.0526 | 0.0792 | |
| Operating Cash Flow Per Share | 19.41 | 23.37 | 23.69 | 27.97 | 31.32 | 32.89 | |
| Stock Based Compensation To Revenue | 0.002901 | 0.002656 | 0.002804 | 0.002871 | 0.00285 | 0.002356 | |
| Pb Ratio | 4.63 | 4.87 | 6.31 | 6.1 | 5.5 | 3.18 | |
| Ev To Sales | 1.18 | 1.29 | 1.41 | 1.75 | 1.65 | 1.43 | |
| Free Cash Flow Per Share | 17.24 | 21.2 | 21.09 | 24.98 | 27.67 | 29.06 | |
| Net Income Per Share | 14.55 | 16.23 | 18.33 | 21.47 | 24.12 | 25.32 | |
| Payables Turnover | 8.51 | 8.69 | 8.9 | 8.42 | 8.78 | 8.34 | |
| Capex To Revenue | (0.00862) | (0.008023) | (0.008602) | (0.008698) | (0.009111) | (0.009567) | |
| Cash Per Share | 14.98 | 20.84 | 25.35 | 29.79 | 31.93 | 33.52 | |
| Pocfratio | 15.14 | 15.01 | 21.19 | 18.96 | 16.81 | 15.05 | |
| Interest Coverage | 12.39 | 11.55 | 13.47 | 14.44 | 9.97 | 15.63 | |
| Pfcf Ratio | 17.06 | 16.54 | 23.81 | 21.23 | 19.02 | 17.95 | |
| Days Payables Outstanding | 42.9 | 41.99 | 41.0 | 43.37 | 41.56 | 31.97 | |
| Ev To Operating Cash Flow | 16.75 | 16.21 | 22.3 | 20.26 | 18.25 | 11.1 | |
| Pe Ratio | 20.2 | 21.61 | 27.39 | 24.69 | 21.83 | 14.11 | |
| Ev To Free Cash Flow | 18.87 | 17.86 | 25.05 | 22.69 | 20.66 | 13.2 | |
| Earnings Yield | 0.0495 | 0.0463 | 0.0365 | 0.0405 | 0.0458 | 0.0266 | |
| Net Debt To E B I T D A | 1.45 | 1.12 | 1.0 | 1.15 | 1.16 | 1.21 | |
| Tangible Book Value Per Share | (14.56) | (12.28) | (9.93) | (22.85) | (21.56) | (20.48) | |
| Receivables Turnover | 20.32 | 19.86 | 20.07 | 18.22 | 9.54 | 9.06 | |
| Graham Number | 144.25 | 162.15 | 181.17 | 204.93 | 227.81 | 239.21 | |
| Shareholders Equity Per Share | 56.41 | 63.55 | 79.58 | 86.93 | 95.64 | 100.42 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.16 | Dividend Share 7.52 | Earnings Share 23.87 | Revenue Per Share 411.257 | Quarterly Revenue Growth 0.086 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.